XellSmart Receives Fourth Consecutive US FDA China NMPA IND Clearance for MSA-P iPSC-derived Cell Therapy Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4898731_CN98731_0